Novel Oncogenic Protein Kinase Inhibitors for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
449-455
Author(s):
Tomi K. Sawyer
Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
4
Page:
461-463
Author(s):
Francois Martin and Eric Solary
p53: Fighting Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
385-402
Author(s):
Galina Selivanova
Novel Strategies in Cancer Therapeutics: Targeting Enzymes Involved in Cell Cycle Regulation and Cellular Proliferation
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
403-424
Author(s):
M. C. Liu, J. L. Marshall and R. G. Pestell
Therapeutic Potential of Hammerhead Ribozymes in the Treatment of Hyper-Proliferative Diseases
Journal:
Current Pharmaceutical Biotechnology
Volume:
5
Page:
369-386
Author(s):
G. Grassi, P. Dawson, G. Guarnieri, R. Kandolf and M. Grassi
Ribozymes in the Age of Molecular Therapeutics
Journal:
Current Molecular Medicine
Volume:
4
Page:
489-506
Author(s):
Sepideh Bagheri and Mohammed Kashani-Sabet
Silencing of Disease-related Genes by Small Interfering RNAs
Journal:
Current Molecular Medicine
Volume:
4
Page:
507-517
Author(s):
U. Fuchs, C. Damm-Welk and A. Borkhardt
Therapeutic Antibodies
Journal:
Current Molecular Medicine
Volume:
4
Page:
539-547
Author(s):
Bernd Groner, Cord Hartmann and Winfried Wels
DNA Methylation Leaves Its Mark in Head and Neck Squamous Cell Carcinomas (HNSCC)
Journal:
Current Genomics
Volume:
5
Page:
489-498
Author(s):
L. T. Smith and C. Plass
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2289-2298
Author(s):
Richard Piekarz and Susan Bates